1. Author's Information
    Brian L. Knight
    Lipoprotein Group, MRC Clinical Sciences Centre, Faculty of Medicine Imperial College, Hammersmith Hospital, London W12 ONN, UK.

    Abdel Hebbachi
    Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, U.K.

    David Hauton
    Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, U.K.

    Anna-Marie Brown
    Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, U.K.

    David Wiggins
    Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, U.K.

    Dilip D. Patel
    Lipoprotein Group, MRC Clinical Sciences Centre, Faculty of Medicine Imperial College, Hammersmith Hospital, London W12 ONN, UK.

    Geoffrey F. Gibbons
    Metabolic Research Laboratory, Oxford Centre for Diabetes, Endocrinology and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, U.K.

  2. Abstract
    Inclusion of the PPARα (peroxisome-proliferator-activated receptor α) activator WY 14,643 in the diet of normal mice stimulated the hepatic expression of not only genes of the fatty acid oxidation pathway, but also those of the de novo lipid synthetic pathways. Induction of fatty acid synthase mRNA by WY 14,643 was greater during the light phase of the diurnal cycle, when food intake was low and PPARα expression was high. Hepatic fatty acid pathway flux in vivo showed a similar pattern of increases. The abundance of mRNAs for genes involved in hepatic cholesterol synthesis was also increased by WY 14,643, but was associated with a decrease in cholesterogenic carbon flux. None of these changes were apparent in PPARα-null mice. Mice of both genotypes showed the expected decreases in 3-hydroxy-3-methylglutaryl-CoA reductase mRNA levels and cholesterol synthesis in response to an increase in dietary cholesterol. The increase in fatty acid synthesis due to WY 14,643 was not mediated by increased expression of SREBP-1c (sterol regulatory element binding protein-1c) mRNA, but by an increase in cleavage of the protein to the active form. An accompanying rise in stearoyl-CoA desaturase mRNA expression suggested that the increase in lipogenesis could have resulted from an alteration in membrane fatty acid composition that influenced SREBP activation.
    Keywords
    cholesterol and fatty acid synthesis, fibrate, gene expression, peroxisome-proliferator-activated receptor α (PPARα), PPARα-null mice, sterol regulatory element binding protein (SREBP)

    ADLID: 35840-v4
  3. Post New Comments

  1. Keywords
    cholesterol and fatty acid synthesis fibrate gene expression peroxisome-proliferator-activated receptor α (PPARα) PPARα-null mice sterol regulatory element binding protein (SREBP)
Want to Index your journal in the ADL?
Suggest a Journal